A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants

Clinical trial NCT07294235 · RECRUITING

Trial details

NCT number: NCT07294235
Sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight or Obesity

Start date: 2025-12-05
Primary completion: 2026-03-02
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.